The relationship between lower urinary tract symptoms and health status: The UREPIK study

BJU International

Volumn 92, Issue 6, 2003, Pages 575-580

  Boyle, P ^a   Robertson, C ^a   Mazzetta, C ^a   Keech, M ^f   Hobbs, R ^b   Fourcade, R ^c   Kiemeney, L ^d   Lee, C ^e  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c Service d'Urologie   (France)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Seoul National University Hospital   (South Korea)

^f NONE

Author keywords

Bother; BPH; Epidemiology; LUTS; Men; Symptoms; Women

Indexed keywords

ADULT; AGED; ARTICLE; COMMUNITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; CULTURAL ANTHROPOLOGY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FRANCE; HEALTH STATUS; HEALTH SURVEY; HUMAN; HYPOTHESIS; INFORMATION PROCESSING; KOREA; LINGUISTICS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NETHERLANDS; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; REGRESSION ANALYSIS; SCORING SYSTEM; SEXUALITY; STUDY; SYMPTOM; UNITED KINGDOM; URETHRA DISEASE;

ADULT; AGED; ENGLAND; FEMALE; FOLLOW-UP STUDIES; FRANCE; HEALTH STATUS; HUMANS; KOREA; MALE; MIDDLE AGED; NETHERLANDS; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; SEX DISTRIBUTION; STATISTICS; URINATION DISORDERS;

EID: 0142124031     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04448.x     Document Type: Article

References (22)

1. Girman CJ, Jacobsen SJ, Tsukamoto T et al. Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology 1998; 51: 428-36
2. Oishi K, Boyle P, Barry MJ et al. Epidemiology and Natural history of BPH. In Denis LJ, Murphy G, Khoury S eds. Proceedings of Fourth International Consultation on Benign Prostatic Hyperplasia. Jersey: SCI, 1998
3. Boyle P, Keech M, Nonis A et al. A cross-sectional survey of benign prostatic hyperplasia, urinary incontinence and male erectile dysfunction, prostatitis and interstitial cystitis in the United Kingdom, France, the Netherlands and Korea. J Epidemiol Biostatistics 1998; 3: 179-87
4. Boyle P, Robertson C, Mazzetta C et al. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int 2003; 92: 409-14
5. Blanker MH, Driessen LF, Bosch JL et al. Health status and its correlates among Dutch community-dwelling older men with and without lower urogenital tract dysfunction. Eur Urol 2002; 41: 602-7
6. Trueman P, Hood SC, Nayak US, Mrazek MF. Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK. BJU Int 1999; 83: 410-5
7. Sells H, Donovan J, Ewings P, MacDonagh RP. The development and validation of a quality-of-life measure to assess partner morbidity in benign prostatic enlargement. BJU Int 2000; 85: 440-5
8. Barry MJ, Fowler FJJ, O'Leary MP et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549-57
9. Robertson C, Boyle P, Nonis A, Merzenich H. Cultural and Linguistic Validation of Questionnaires to Assess BPH-Related Urinary Symptoms and Associated Quality-of-Life Aspects. Final Report of Project supported by a research grant from GlaxoWellcome. Milan: European Institute of Oncology, 1999: 1-143
10. Barry MJ, Fowler FJJ, O'Leary MP et al. Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of the AUA. Med Care 1995; 33 (Suppl.4): AS145-55
11. Barry MJ, Williford WO, Chang Y et al. Benign prostatic hyperplasia specific health status measures in clinical research, how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol 1995; 154: 1770-4
12. Gandek B, Ware JE, Aaronson NK et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project on International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1171-8
13. Armitage P, Berry G. Statistical Methods in Medical Research. Vol 3. Oxford: Blackwell Science, 1994
14. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74
15. McCullagh P. Regression models for ordinal data (with discussion). J Royal Stat Soc 1980; 42: 109-42
16. Yu HJ, Chen J, Lai MK, Chan KA, Chie WC. High prevalence of voiding symptoms in Taiwanese women. Br J Urol 1998; 82: 520-3
17. Namasivayam S, Minhas S, Brooke J, Joyce AD, Prescott S, Eardley I. The evaluation of sexual function in men presenting with symptomatic benign prostatic hyperplasia. Br J Urol 1998; 82: 842-6
18. Arocho R, McMillan CA, Sutton-Wallace P. Construct validation of the USA-Spanish version of the SF-36 health survey in a Cuban-American population with benign prostatic hyperplasia. Quality Life Res 1998; 7: 121-6
19. Hunter DJ, McKee M, Black NA, Sanderson CF. Health status and quality of life of British men with lower urinary tract symptoms: results from the SF-36. Urology 1995; 45: 962-71
20. Mozes B, Maor Y, Shmueli A. The competing effects of disease states on quality of life of the elderly: the case of urinary symptoms in men. Quality Life Res 1999; 8: 93-9
21. Sarma AV, Jacobsen SJ, Girman CJ et al. Concomitant longitudinal changes in frequency of and bother from lower urinary tract symptoms in community dwelling men. J Urol 2002; 168: 1446-52
22. Koskimaki J, Hakama M, Huhtala H, Tammela TL. Is reduced quality of life in men with lower urinary tract symptoms due to concomitant diseases? Eur Urol 2001; 40: 661-5